Research progress and applications of epigenetic biomarkers in cancer
Frontiers in Pharmacology · 12.04.2024 · 15
DOI: 10.3389/fphar.2024.1308309 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.04.2024. Verfasst von Jianjun Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigenetic changes are heritable changes in gene expression without changes in the nucleotide sequence of genes. Epigenetic changes play an important role in the development of cancer and in the process of malignancy metastasis. Previous studies have shown that abnormal epigenetic changes can be used as biomarkers for disease status and disease prediction. The reversibility and controllability of epigenetic modification changes also provide new strategies for early disease prevention and treatment. In addition, corresponding drug development has also reached the clinical stage. In this paper, we will discuss the recent progress and application status of tumor epigenetic biomarkers from three perspectives: DNA methylation, non-coding RNA, and histone modification, in order to provide new opportunities for additional tumor research and applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of General Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Zitieren
APA
Gao, J., Shi, W., Wang, J., Guan, C., Dong, Q., Sheng, J., Zou, X., Xu, Z., Ge, Y., Yang, C., Li, J., Bao, H., Zhong, X., & Cui, Y. (2024). Research progress and applications of epigenetic biomarkers in cancer. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1308309
Vancouver
Gao J, Shi W, Wang J, Guan C, Dong Q, Sheng J, et al. Research progress and applications of epigenetic biomarkers in cancer. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1308309
BibTeX
@article{Gao2024,
author = {Gao, Jianjun and Shi, Wujiang and Wang, Jiangang and Guan, Canghai and Dong, Qingfu and Sheng, Jialin and Zou, Xinlei and Xu, Zhaoqiang and Ge, Yifei and Yang, Chengru and Li, Jiehan and Bao, Haolin and Zhong, Xiangyu and Cui, Yunfu},
title = {Research progress and applications of epigenetic biomarkers in cancer},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1308309}
}
EUVIMED